Denise M O'hara

Title: Denise M O'Hara: Innovator in Immunoconjugates for Inflammatory Bowel Disease

Introduction

Denise M O'Hara is a prominent inventor based in Andover, MA (US). She has made significant contributions to the field of medical research, particularly in the development of immunoconjugates for treating inflammatory bowel disease (IBD). Her innovative work has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

Denise holds a patent for "Anti-ED-A immunoconjugates for inflammatory bowel disease." This patent involves specific binding members that target the ED-A isoform of fibronectin. These members are designed for use in methods of treatment, diagnosis, detection, and imaging of IBD. Additionally, they can facilitate the delivery of molecules conjugated to the specific binding member, which may include immunosuppressive or anti-inflammatory agents like interleukin-10. Denise has 1 patent to her name.

Career Highlights

Denise has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Philogen S.p.a., where she continues to advance her work on immunoconjugates. Her dedication to improving treatment options for IBD patients is evident in her research endeavors.

Collaborations

Denise has collaborated with notable colleagues, including Giovanni Neri and Kathrin Schwager. These partnerships have contributed to the advancement of her research and the development of new therapeutic strategies.

Conclusion

Denise M O'Hara is a trailblazer in the field of immunoconjugates, with a focus on inflammatory bowel disease. Her innovative patent and collaborative efforts highlight her commitment to advancing medical research and improving patient outcomes.